Phototherapy Market Size

Market Size Snapshot

Note – Market size depicts the revenue generated over the financial year

The phototherapy market is projected to grow at a CAGR of 5.1% from 2024 to 2032, reaching a size of USD 62 million in 2024. The increasing demand for phototherapy is driven by an increase in the awareness of skin diseases and the rising prevalence of skin disorders such as psoriasis, eczema, and neonatal jaundice. The market is expected to benefit from the technological advancements and new treatment methods. LED and laser-based phototherapy devices have a better safety profile and efficacy than the conventional light boxes. Strategic initiatives such as the launch of new products and the establishment of strategic alliances are also expected to drive the market. Companies such as Philips HealthCare, Daavlin, and BioLite are expected to be the major contributors to the market growth, through the launch of new products and strategic alliances.

Regional Market Size

Regional Deep Dive

The phototherapy market is growing at a fast pace in all regions, driven by the rising awareness of skin disorders, the advancement of technology, and the growing preference for non-invasive treatments. North America is characterized by the high penetration of phototherapy devices. Europe is characterized by a strong regulatory framework that encourages the development of new therapies. The Asia-Pacific region is characterized by rapid growth due to the rising expenditure on health and the growing population of people with skin problems. Middle East and Africa are slowly adopting phototherapy solutions, which is driven by the increasing investments in the health care system and the rising awareness of skin disorders. Latin America is also a potential market for phototherapy, which is driven by the growing demand for aesthetic treatments and the management of skin disorders.

Europe

• The European Medicines Agency (EMA) has introduced streamlined regulations for phototherapy devices, facilitating faster market entry for innovative products and encouraging investment in the sector.
• Countries like Germany and the UK are leading in the adoption of home-use phototherapy devices, driven by a cultural shift towards self-care and convenience in managing skin conditions.

Asia Pacific

• The rise of telemedicine in countries like India and China is enabling remote consultations and treatment plans, which is increasing the accessibility of phototherapy for patients in rural areas.
• Government initiatives aimed at improving healthcare infrastructure are promoting the adoption of phototherapy devices, with organizations like the Indian Ministry of Health and Family Welfare supporting awareness campaigns.

Latin America

• Brazil is emerging as a key market for phototherapy, with increasing investments in dermatological clinics and a growing awareness of skin health among the population.
• Regulatory bodies in countries like Mexico are working to establish clearer guidelines for phototherapy devices, which is anticipated to enhance market confidence and encourage new entrants.

North America

• The FDA has recently approved several new phototherapy devices, enhancing treatment options for conditions like psoriasis and eczema, which is expected to boost market growth significantly.
• Key players such as Philips and Daavlin are investing in R&D to develop advanced phototherapy solutions, focusing on user-friendly designs and improved efficacy, which is likely to increase patient compliance.

Middle East And Africa

• The UAE is witnessing a surge in dermatology clinics offering phototherapy treatments, supported by government initiatives to enhance healthcare services and attract medical tourism.
• Local companies are collaborating with international firms to introduce advanced phototherapy technologies, which is expected to improve treatment outcomes and expand market reach.

Did You Know?

“Phototherapy has been used for over 100 years to treat skin conditions, but recent advancements have made it more effective and accessible than ever before.” — American Academy of Dermatology

Segmental Market Size

The phototherapy market is growing steadily, mainly due to the growing awareness of skin problems and the rising prevalence of such conditions as psoriasis and eczema. A number of factors are also driving growth, including technological advancements in light-based therapies and a growing emphasis on non-invasive treatment options. Authorities are also increasingly recommending the use of phototherapy for a range of skin conditions. In terms of the adoption of phototherapy, the stage of deployment is now in the scaled deployment phase, with Philips and Daavlin offering the most comprehensive product portfolios. North America and Europe lead the way in terms of the clinical use of phototherapy and the use of phototherapy in the home. There is a high level of usage of blue light therapy lamps and of devices that emit short-wavelength light. Blue light therapy lamps and devices emitting short-wavelength light are also used to treat infant jaundice. In addition, macro-economic trends such as the rising focus on mental health and well-being and the growing emphasis on eco-friendly treatment options are driving growth in this market. And as for the future of phototherapy, the development of LEDs and the emergence of portable phototherapy devices will be key factors.

Future Outlook

From 2024 to 2032, the phototherapy market is expected to increase from $ 62 million to $ 102 million, at a CAGR of 5.1%. The increase in the prevalence of skin diseases such as psoriasis and eczema, combined with the growing awareness of the advantages of non-invasive treatments, will increase the use of this method of treatment. The phototherapy market will also be influenced by the increase in the penetration of home and hospital phototherapy. In 2032, it is expected that phototherapy will be used in approximately 15 to 20% of dermatological treatments, up from the current 10 to 15%. Technological innovations, such as the development of portable and easy-to-use devices, will also stimulate the phototherapy market. LED and smart light will improve the effectiveness of treatment and patient compliance. Furthermore, supportive reimbursement policies and the development of new reimbursement frameworks will increase the access to phototherapy treatments. Also, the integration of phototherapy with other methods of treatment, such as pharmacotherapy and surgery, will ensure that phototherapy remains an integral part of modern dermatological care.